Type
Buy
Instrument
CADILAHC AUG20 FUT
Entry Price
₹398.15
Price@Trade
₹398.5
Target Price
₹408
Stop Price
₹390
Valid Till
Aug 5, 2020 3:20 AM
Margin
₹208,928.5 approx for 2200 Qty
Status
Waiting for entry
FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors
CADILAHC
397.25
-6.45 (-1.6%)
Updated 01:02 05/08 IST
CADILAHC Buy or Sell - FrontPage Forums
0 Users have submitted 0 trade ideas of Rs. 0 for CADILAHC
Disclaimer0% Bullish
0% Bearish
CADILAHC Buy or Sell - Brokerage Reports
No. of reports in last year
12
No. of analysts
6
Average Consensus Forecast
291.08
Consensus Potential
-40.18%
CADILAHC Ratings
Long term CADILAHC rating by FrontPage users
- ★★
- ★★
- ★★
- ★★
- ★★
4.3/5 (7 Ratings)
Find answers to all your questions on live CADILAHC message board: Is CADILAHC buy or sell? Should I buy CADILAHC shares? Why are CADILAHC shares falling? Should I invest in CADILAHC stock?
- Home
- CADILAHC Forum
CADILAHC Share Price Discussion
Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine from August 6
"ZyCoV-D was found to be safe and well tolerated in the phase I clinical trial. The company will now commence phase II clinical trials from the 6th of August, 2020.
"ZyCoV-D was found to be safe and well tolerated in the phase I clinical trial. The company will now commence phase II clinical trials from the 6th of August, 2020.
Moneycontrol
Like
Reply
Zydus Cadila to commence phase II clinical trials of COVID-19 vaccine ZyCoV-D from Aug 6
"The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15, 2020, has been well tolerated," Cadila Healthcare, the listed entity of the group, said in a regulatory filing. Zydus Cadila Chairman Pankaj R Patel said the phase I dosing to establish the safety of ZyCoV-D is an important milestone.
"The company reports that the doses of the vaccine administered to healthy volunteers in the phase I clinical trial, which began on July 15, 2020, has been well tolerated," Cadila Healthcare, the listed entity of the group, said in a regulatory filing. Zydus Cadila Chairman Pankaj R Patel said the phase I dosing to establish the safety of ZyCoV-D is an important milestone.
The Economic Times
Like
Reply
S
Reputation: 41,096 • Yesterday 4:59 AM
Bharat Biotech, Zydus Cadila complete phase I of Covid-19 vaccine trials
The completion of trials in a short period of time—enrolment and human dosing of the vaccine candidates had started only in mid-July—is likely to be unprecedented
The completion of trials in a short period of time—enrolment and human dosing of the vaccine candidates had started only in mid-July—is likely to be unprecedented
Livemint
Bharat Biotech, Zydus Cadila complete phase I of Covid-19 vaccine trials https://www.livemint.com/news/india/bharat-biotech-zydus-...
Download mint app for latest in Business News - https://bit.ly/32XEfFE
1
Reply
P
Reputation: 3,686 • Yesterday 8:44 AM
Pyramidstock in CADILAHCCadila btst cmp 400-401 Sl 389 tgt 410-420 resu...
405.35 high #CADILAHC
Like
Reply
P
Reputation: 3,686 • Yesterday 7:35 AM
Cadila btst cmp 400-401 Sl 389 tgt 410-420 result tomorrow #CADILAHC
Like
Reply
N
Reputation: 4,657 • Yesterday 5:36 AM
LIVE Market Technicals with CK Narayan
Strong trends are visible on Cadila chart ahead of the results tomorrow.
Strong trends are visible on Cadila chart ahead of the results tomorrow.
The Economic Times
Like
Reply
S
Reputation: -46,321 • Aug 3 6:33 AM
It's Education Purpose Only. Pleased Don't Follow this Trade Before Self Analysis. It Would Be Harming For You,
Like
Reply (1)
Latest replies
V
Reputation: 5,065 • Aug 3 2:52 AM
vijay jaria in CADILAHCGovt considering hike in API import duties.. P...
1
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
- keyboard_arrow_down
CADILAHC Share Price - Technicals
- NewsBotJust nowZydus Cadila to commence phase II clinical trials of COVID-19 vaccine from August 6MoneycontrolNewsBotJust nowZydus Cadila to commence phase II clinical trials of COVID-19 vaccine ZyCoV-D from Aug 6The Economic TimesNewsBotYesterday 5:36 AMLIVE Market Technicals with CK NarayanThe Economic TimesNewsBotAug 2 5:38 AM
US generics business to continue its growth momentum: Cadila HealthcareMoneycontrolNewsBotAug 2 5:11 AM
US generics business to continue its growth momentum: Pharma firm Cadila HealthcareThe Economic TimesNewsBotJul 31 1:53 AM
Remdesivir shortage to ease in August as existing suppliers boost capacity, new manufacturers enterMoneycontrolNewsBotJul 31 1:13 AM
Hot Stocks | Cadila, ICICI Bank may give up to 16% return in short termMoneycontrolNewsBotJul 29 3:08 AM
Dr Reddy's expects to launch Remdesivir in AugustMoneycontrolNewsBotJul 25 1:53 AM
COVID-19: Import licenses for rapid diagnostic kits of 3 firms cancelled, 15 suspended by DCGIMoneycontrolNewsBotJul 25 2:56 AM
Much headway in quest for vaccine: Drugmakers might be one step away from the Covid remedyThe Economic Times
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.